Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Immix Biopharma, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −6 vs. Q4 2022
- Shares held
- 400.8K
- −40.0K (−9.1%) vs. Q4 2022
- Total value
- $729.8K
- −$281.4K (−27.8%) vs. Q4 2022
- New holders
- 3
- 4 more added
- Sold out
- 9
- 1 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 38 | $69 | 0.00% | +1+2.7% | Added |
| Advisor Group Holdings, Inc. | 350 | $637 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,301 | $4.19K | 0.00% | −2,386−50.9% | Reduced |
| Tower Research Capital LLC (TRC) | 6,375 | $12.0K | 0.00% | +4,019+170.6% | Added |
| Ground Swell Capital, LLC | 10,692 | $19.5K | 0.03% | +10,692 | New |
| InterOcean Capital Group, LLC | 15,900 | $28.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 17,723 | $32.3K | 0.00% | +17,723 | New |
| Moss Adams Wealth Advisors LLC | 20,078 | $36.5K | 0.01% | +78+0.4% | Added |
| State Street Corp | 42,960 | $78.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 79,722 | $145.1K | 0.00% | +3,185+4.2% | Added |
| Umb Bank N A | 99,300 | $180.7K | 0.00% | +99,300 | New |
| Vanguard Group Inc | 105,357 | $191.8K | 0.00% | 00.0% | Unchanged |
| Murchinson Ltd. | 0 | $0 | 0.00% | −67,200−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −33,600−100.0% | Sold out |
| Lynwood Capital Management Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −19,151−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,597−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1−100.0% | Sold out |